Editor's Note: This article is part of Medical Bankruptcy in America, a Patients Rising series examining how medical debt appears in federal bankruptcy filings across the United States. The cases referenced come from publicly filed court records. To protect personal privacy, we focus on the financial details and creditor listings rather than identifying the individuals involved.

Medical bankruptcy rarely begins with a single moment. It usually begins with a diagnosis, a hospital visit, or a treatment that arrives when life is already financially fragile. When medical bills accumulate faster than a household can absorb them, the consequences often appear in federal bankruptcy court records — where hospital systems, physician groups, and collection agencies are listed as creditors alongside credit cards and personal loans.

For one Virginia resident whose bankruptcy filing appears in federal court records, the tipping point included a hospital bill of more than $20,000 owed to Bon Secours, a large nonprofit hospital system participating in the federal 340B drug pricing program.

In the bankruptcy schedules, Bon Secours appears as one of the largest creditors in the case, with a medical claim totaling $20,676.

That amount alone would be overwhelming for many families. But medical debt rarely arrives alone.

Like many Americans facing a serious health event, the financial pressure extended beyond the hospital itself. Additional medical providers were listed among the creditors, including physician and anesthesiology services tied to the same episode of care. Medical bills accumulated across multiple providers — each one adding another layer of financial strain.

By the time the individual filed for Chapter 7 bankruptcy protection, the total unsecured debts had grown far beyond what could reasonably be repaid.

Court records show total liabilities of approximately $74,780, while monthly expenses exceeded income — leaving little room to recover from large unexpected bills.

The financial picture that emerges from the filing is one that has become increasingly familiar across the United States.

A medical event triggers hospital care.
The hospital generates the largest bill.
Specialists and related providers generate additional bills.

And when insurance, savings, and payment plans are not enough, the debt becomes impossible to manage.

At that point, bankruptcy becomes the last remaining financial reset.

This story is not unique.

Across bankruptcy filings reviewed by Patients Rising, nonprofit hospitals — including many that participate in the federal 340B drug pricing program — appear repeatedly as creditors in cases involving medical debt.

The 340B program was created by Congress to help hospitals serving vulnerable patients purchase medicines at deeply discounted prices. The intent was simple: hospitals would use those savings to expand care and help patients who struggle financially.

But court records raise an uncomfortable question.

If hospitals receive federal drug discounts intended to support vulnerable patients, why do so many patients still end up in bankruptcy court with large hospital debts?

Patients Rising believes the answer is not simple. Healthcare billing is complicated, insurance designs are complex, and hospitals operate within a difficult financial environment.

But transparency matters.

And accountability matters.

Patients deserve to know whether programs designed to help them are actually reaching them.

Because when hospital bills reach tens of thousands of dollars, the consequences are not abstract.

They show up in court filings, bankruptcy petitions, and families trying to rebuild their financial lives.

Medical debt is rarely just a number on a balance sheet. It is the intersection of illness, insurance design, hospital billing systems, and household finances. When those forces collide, the results often appear in bankruptcy court. The question policymakers must confront is simple: if programs designed to support vulnerable patients exist, why do so many patients still end up here?